Albany, NY -- (SBWire) -- 01/26/2019 --A recent report by ResearchMoz.us, titled, "Preterm Birth and PROM Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018–2026," furnishes crucial information on the market. The report tries to unravel the forces propelling or hindering the global preterm birth and PROM testing market. It also examines the competitive dynamics and various product and application segments in the market.
The report finds that the global preterm birth and PROM testing market is mainly being driven by the rising instances of preterm births, growing usage of point-of-care testing devices, and increasing demand for cost-effective diagnostic tests. The market is also being buoyed by the surge in effective, early diagnosis and lessening of false positive tests.
Another factor majorly boosting the global preterm birth and PROM testing market is the development of better devices for detection, diagnosis, and care. Both key stakeholders in the market and independent research bodies are expending money on development of more cutting-edge products.
Get a Sample PDF with tables and Figures at : https://www.researchmoz.us/enquiry.php?type=S&repid=2023317
Depending upon the type of tests, the global preterm birth and PROM testing market has been segmented into PROM tests and preterm birth tests. The PROM tests comprise of ferning test, nitrazine test, biomarker, pooling, fetal fibronectin test, ultrasound, and others. The preterm birth tests comprise of ultrasound, pelvic exam, biomarkers, and uterine monitoring. Between the two, the biomarkers for uncovering preterm birth is seeing maximum adoption. PROM tests, apart from biomarkers, such as fetal fibronectin tests and ultrasound are mainly carried out in clinics and hospitals to uncover the possibility of PROM.
In fact, the key end users in the global preterm birth and PROM test market are diagnostics laboratories, hospitals, and others. Of them, hospitals are mainly generating the revenue because of the ultrasound, biomarkers, and fetal fibronectin tests being carried out in them widely.
With respect to geography, the global preterm birth and PROM test market is spread across North America, South America, Europe, Asia Pacific, and the Middle East and Africa. Of them, North America at present leads with maximum share because of the state-of-the-art healthcare facilities in the region. With numerous well-equipped hospitals and clinics, the region is seen contributing significantly to the global preterm birth and PROM test market.
Europe is another major preterm birth and PROM test market. This is because of the superior healthcare infrastructure and technology over there. Going forward, Asia Pacific is expected to emerge as a promising market because of the strengthening healthcare infrastructure in the region, particularly in nations of China and India.
Key players operating in the global preterm birth and PROM test market are Medix Biochemica, QIAGEN, Hologic, Inc., Abbott Laboratories, and Biosynex,Clinical Innovations, LLC. The report provides information on their product offerings, their sales and revenues, and market standing. It also offers insights into the opportunities and pitfalls that the players might encounter in the near term.
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Rising Cases of Preterm Births Bolster Global Preterm Birth and PROM Testing Market